Precision BioSciences Files Definitive Proxy Statement

Ticker: DTIL · Form: DEF 14A · Filed: Apr 15, 2025 · CIK: 1357874

Precision Biosciences Inc DEF 14A Filing Summary
FieldDetail
CompanyPrecision Biosciences Inc (DTIL)
Form TypeDEF 14A
Filed DateApr 15, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, governance, annual-meeting

Related Tickers: PBIO

TL;DR

PBIO proxy filed, shareholders vote on directors & pay May 28.

AI Summary

Precision BioSciences Inc. filed its definitive proxy statement on April 15, 2025, for its annual meeting of stockholders on May 28, 2025. The filing, under the 1934 Securities Exchange Act, details matters to be voted on by shareholders, including the election of directors and executive compensation. The company is based in Durham, NC, and operates in the biological products sector.

Why It Matters

This filing provides shareholders with crucial information regarding company governance, director elections, and executive compensation, enabling them to make informed voting decisions at the upcoming annual meeting.

Risk Assessment

Risk Level: low — This is a routine proxy filing, not indicating immediate financial distress or significant new risks.

Key Numbers

  • 20250415 — Filing Date (Date the definitive proxy statement was filed.)
  • 20250528 — Meeting Date (Date of the annual meeting of stockholders.)

Key Players & Entities

  • PRECISION BIOSCIENCES INC (company) — Registrant
  • 0001140361-25-013867 (filing_id) — Accession Number
  • 20250415 (date) — Filing Date
  • 20250528 (date) — Meeting Date
  • DURHAM, NC (location) — Company Headquarters

FAQ

What is the purpose of this DEF 14A filing?

The purpose of this DEF 14A filing is to provide shareholders with a definitive proxy statement for the annual meeting of stockholders, detailing matters to be voted upon.

When is the annual meeting of stockholders scheduled?

The annual meeting of stockholders is scheduled for May 28, 2025.

Who is the registrant filing this proxy statement?

The registrant filing this proxy statement is Precision BioSciences, Inc.

What is the company's primary business sector?

The company's primary business sector is Biological Products (No Diagnostic Substances).

Where is Precision BioSciences, Inc. located?

Precision BioSciences, Inc. is located at 302 East Pettigrew Street, Suite A-100, Durham, NC 27701.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 15, 2025 regarding PRECISION BIOSCIENCES INC (DTIL).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.